§ Data to identify target populations are required for all test events conducted in non-health care settings and are only required for HIV-positive persons from health care settings. Therefore, data for target populations were only from tests conducted in non-health care settings (N = 879,063 for all CDCfunded test events and N = 197,802 for Hispanics/Latinos). Health care settings include inpatient facilities, outpatient facilities, and emergency departments. Non-health care settings include HIV counseling and testing sites and community settings. ¶ An HIV test event is a sequence of one or more HIV tests conducted to determine a person's HIV status. During one testing event, a person might be tested once (e.g., one rapid test or one conventional test) or multiple times (e.g., one rapid test followed by one conventional test to confirm a preliminary HIV-positive test result). ** HIV prevalence is defined based on the number of persons living with diagnosed HIV infection (PLWH) in 2013. The jurisdictions are classified based on HIV prevalence as follows: high, ≥20,000 PLWH; medium, 4,000-19,999 PLWH; medium-low, 1,000-3,999 PLWH; and low, <1,000 PLWH. † † MSM include males who reported male-to-male sexual contact as well as males who reported both male-to-male sexual contact and injection drug use in the past 12 months. Persons who inject drugs include persons who reported injection drug use in the past 12 months. Heterosexual males include males who only reported heterosexual contact with a female in the past 12 months. § The jurisdictions are grouped according to HIV prevalence and based on the number of persons living with diagnosed HIV infection in 2013: high = ≥20,000; medium = 4,000-19,999; medium-low = 1,000-3,999; and low = <1,000. ¶ Data to identify target populations are required for all test events conducted in non-health care settings and only required for persons with HIV infection from health care settings. Therefore, for target populations, data are only from non-health care settings (N = 879,063 for all test events, N = 197,802 for test events among Hispanics/Latinos, and N = 1,222 for Hispanics/Latinos newly diagnosed with HIV infection). Other target populations and missing data among Hispanics/Latinos include the following: transgender = 1.1%, women who have sex with women = 0.9%, persons not reporting sex with male or female or injection drug use = 17.4%, and missing/invalid = 18.8%. ** MSM include males who reported male-to-male sexual contact as well as males who reported both male-to-male sexual contact and injection drug use in the past 12 months. Persons who inject drugs include persons who reported injection drug use in the past 12 months. Heterosexual males include males who only reported heterosexual contact with a female in the past 12 months. Heterosexual females include females who only reported heterosexual contact with a male in the past 12 months.
MSM and 22.2% of all persons who inject drugs receiving an HIV diagnosis in non-health care settings (Table 1) (6) , which suggests that improved strategies are needed to increase linkage among Hispanics/Latinos as a critical step in achieving viral suppression. Effective public health strategies also are needed to strengthen partner services and increase referrals for risk-reduction services among Hispanics/ Latinos, especially among Hispanics/Latinos in the South. Given these data, prevention efforts that include targeted specific geographic regions might increase early diagnosis and improve HIV-related health outcomes among Hispanics/Latinos (7).
The findings in this report are subject to at least three limitations. First, the findings describe HIV tests conducted at CDC-funded health departments and community-based organizations only and are not representative of all HIV testing in the United States. Second, data on referral and linkage to HIV medical care, partner services, and risk-reduction services represent the minimum percentage (i.e., include records without valid data on the outcome in the denominator) achieved and likely underestimate the percentage referred and linked. Finally, collection of data on target populations is required in all non-health care settings but only for HIV-positive test events in all health care settings; therefore, underreporting the number of test events conducted among target populations.
Broader implementation of routine HIV screening and targeting testing among Hispanics/Latinos, most notably MSM and transgender persons, as recommended by CDC guidelines (8) and the U.S. Preventive Services Task Force (9) is critical to identify persons who are unaware of their HIV status. Programmatic strategies (e.g., HIV preexposure prophylaxis)
Summary
What is already known about this topic?
In 2014, 23% of HIV diagnoses were among Hispanics/Latinos, who made up 16% of the U.S. population. In 2014, the rate of HIV diagnoses among Hispanics/Latinos was approximately three times that for non-Hispanic whites (18.4 compared with. 6.1 per 100,000 population).
What is added by this report?
The analysis showed that Hispanics/Latinos accounted for 22.6% of CDC-funded HIV testing events and 23.3% of persons with newly diagnosed HIV infection. The percentages of Hispanics/Latinos linked to HIV medical care, interviewed for partner services, and referred to prevention services were lower in the South compared with other U.S. census regions. Approximately 60% of Hispanics/Latinos were linked to medical care within 90 days of diagnosis, which is below the 85% goal of the National HIV/AIDS Strategy.
What are the implications for public health practice?
The findings emphasize the need for culturally and linguistically sensitive prevention strategies to promote diagnosis of HIV infection and linkage to medical care among Hispanics/Latinos to improve health outcomes. Stakeholders and partners should focus on prevention and care strategies for Hispanic/Latino subpopulations (e.g., men who have sex with men and persons who inject drugs) to reduce HIV-related disparities.
for HIV-negative persons at high risk (especially racial/ethnic minorities and MSM) that complement existing prevention efforts are important to reduce the risk for HIV infection (10) . CDC offers bilingual resources to raise awareness about HIV and testing among Hispanics/Latinos, including its newest campaign, Doing It, which is intended to motivate adults to get tested. § § Barriers to accessing and receiving HIV testing among Hispanics/Latinos include lack of health insurance, lower educational status, stigma or fear of discrimination, and fear of disclosing immigration status. ¶ ¶ HIV prevention § § http://www.cdc.gov/actagainstaids/campaigns/doingit/. ¶ ¶ http://www.cdc.gov/hiv/group/racialethnic/hispaniclatinos/index.html. † Included are persons who tested HIV-positive and did not report a previous positive test result, calculated using HIV surveillance verification (if available) or a person's self-reported previous HIV status. The denominator for diagnosed persons is the number of HIV test events. The denominator for linkage, HIV partner services, and HIV risk reduction services is the number of diagnosed persons. § The jurisdictions are grouped according to HIV prevalence and based on the number of persons living with diagnosed HIV infection in 2013: high = ≥20,000; medium = 4,000-19,999; medium-low = 1,000-3,999; and low = <1,000. ¶ Data to identify target populations are required for all test events conducted in non-health care settings and only required for persons with HIV infection from health care settings. Therefore, for target populations, data are only from non-health care settings (N = 879,063 for all test events, N = 197,802 for test events among Hispanics/Latinos, and N = 1,222 for Hispanics/Latinos newly diagnosed with HIV infection). Other target populations and missing data among Hispanics/Latinos include the following: transgender = 1.1%, women who have sex with women = 0.9%, persons not reporting sex with male or female or injection drug use = 17.4%, and missing/invalid = 18.8%. ** MSM include males who reported male-to-male sexual contact as well as males who reported both male-to-male sexual contact and injection drug use in the past 12 months. Persons who inject drugs include persons who reported injection drug use in the past 12 months. Heterosexual males include males who only reported heterosexual contact with a female in the past 12 months. Heterosexual females include females who only reported heterosexual contact with a male in the past 12 months.
programs that focus on culturally and linguistically sensitive prevention strategies to increase testing, enhance linkage to HIV care and partner services, and promote community-level risk-reduction services for Hispanics/Latinos might reduce health disparities and HIV transmission.
